Buffett’s Cancer No Reason to Sell Berkshire: Tilson

Berkshire Hathaway is hedge fund manager Whitney Tilson’s largest position and Tilson tells us he has no plans to make any adjustments despite Warren Buffett's health scare.

“We believe there’s a good chance that Buffett will be running the company for the next 5 years and maybe even the next 10 years and today’s announcement doesn’t change that."

By today's announcement Tilson is referring to word that Buffett has been diagnosed with stage 1 prostate cancer and will begin a 2-month course of treatment of daily radiation.

Tilson has done some Internet research and tells us, “I’m relieved to tell you the 5 year survival rate for stage 1 prostate cancer is 99.9%."

With such an overwhelmingly positive survival rate Tilson says, "I breathe a sign of relief for him personally and as a shareholder."

In fact, Tilson added to his position recently and still believes it was a smart move. He has a rough price target on Berkshire of $180,000 per A-share and says, "we do not factor in one dollar of Warren Buffett premium. We simply take the investments per share and put a modest multiple on the operating earnings on the business."

And if this health care triggers a sharp decline in share price, Tilson tells us, he'll hit the buy button.

What do you think? We want to know!

Vote to see results
Total Votes:

Not a Scientific Survey. Results may not total 100% due to rounding.

Got something to to say? Send us an e-mail at fastmoney-web@cnbc.com and your comment might be posted on the Rapid Recap. If you'd prefer to make a comment, but not have it published on our Web site, send those e-mails to fastmoney@cnbc.com.

Trader disclosure: On April 17, 2012 , the following stocks and commodities mentioned or intended to be mentioned on CNBC’s "Fast Money" were owned by the "Fast Money" traders; Karen Finerman owns HPQ; Joe Terranova owns IBM; Guy Adami owns INTC

For Brian Kelly
Nothing to disclose

For Ken Sena
Nothing to Disclose

For Saw Wu
Sterne, Agee & Leach, Inc. makes a market in the following subject company: IBM
Sterne, Agee & Leach, Inc.’s research analysts receive compensation that is based upon various factors, including Sterne, Agee & Leach, Inc.’s total revenues, a portion of which is generated by investment banking activities.
Sterne Agee & Leach, Inc. expects to receive or intends to seek compensation for investment banking services from the subject company and/or companies in the next three months: IBM

CNBC.com with wires.